Hartford Financial Management Inc. Abbott Laboratories Transaction History

Hartford Financial Management Inc.

$460 Million
Q1 2025

A detailed history of Hartford Financial Management Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Hartford Financial Management Inc. holds 46,874 shares of ABT stock, worth $6.24 Million. This represents 1.35% of its overall portfolio holdings.

Number of Shares

46,874

Previous 47,484 1.28%

Holding current value

$6.24 Million

Previous $5.37 Million 15.77%

% of portfolio

1.35%

Previous 1.16%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 21, 2025	SELL	$111.1 - $140.22 $67,771 - $85,534	-610 Reduced 1.28%	46,874 $6.22 Million
Q4 2024 Jan 23, 2025	SELL	$111.93 - $119.39 $122,675 - $130,851	-1,096 Reduced 2.26%	47,484 $5.37 Million
Q3 2024 Oct 28, 2024	SELL	$100.07 - $118.13 $108,375 - $127,934	-1,083 Reduced 2.18%	48,580 $5.54 Million
Q2 2024 Aug 09, 2024	BUY	$100.73 - $112.44 $8,360 - $9,332	83 Added 0.17%	49,663 $5.16 Million
Q1 2024 Apr 24, 2024	SELL	$109.52 - $120.96 $61,878 - $68,342	-565 Reduced 1.13%	49,580 $5.64 Million
Q4 2023 Jan 29, 2024	BUY	$90.19 - $110.4 $20,112 - $24,619	223 Added 0.45%	50,145 $5.52 Million
Q3 2023 Oct 24, 2023	SELL	$95.53 - $114.62 $3,439 - $4,126	-36 Reduced 0.07%	49,922 $4.83 Million
Q2 2023 Jul 26, 2023	SELL	$100.78 - $112.29 $61,576 - $68,609	-611 Reduced 1.21%	49,958 $5.45 Million
Q1 2023 Apr 25, 2023	SELL	$96.86 - $114.01 $20,050 - $23,600	-207 Reduced 0.41%	50,569 $5.12 Million
Q4 2022 Feb 01, 2023	SELL	$95.06 - $111.52 $120,250 - $141,072	-1,265 Reduced 2.43%	50,776 $5.58 Million
Q3 2022 Oct 25, 2022	SELL	$96.76 - $112.03 $107,887 - $124,913	-1,115 Reduced 2.1%	52,041 $5.04 Million
Q2 2022 Jul 21, 2022	SELL	$102.07 - $123.37 $68,897 - $83,274	-675 Reduced 1.25%	53,156 $5.78 Million
Q1 2022 May 05, 2022	BUY	$114.02 - $139.04 $2,622 - $3,197	23 Added 0.04%	53,831 $6.37 Million
Q4 2021 Jan 27, 2022	SELL	$115.53 - $141.46 $21,835 - $26,735	-189 Reduced 0.35%	53,808 $7.57 Million
Q3 2021 Oct 29, 2021	SELL	$116.66 - $129.06 $11,782 - $13,035	-101 Reduced 0.19%	53,997 $6.38 Million
Q2 2021 Jul 27, 2021	SELL	$105.79 - $124.53 $40,094 - $47,196	-379 Reduced 0.7%	54,098 $6.27 Million
Q1 2021 Apr 14, 2021	SELL	$108.84 - $128.23 $3,809 - $4,488	-35 Reduced 0.06%	54,477 $6.53 Million
Q4 2020 Feb 03, 2021	SELL	$105.0 - $114.42 $26,670 - $29,062	-254 Reduced 0.46%	54,512 $5.97 Million
Q3 2020 Oct 16, 2020	SELL	$91.64 - $111.29 $14,937 - $18,140	-163 Reduced 0.3%	54,766 $5.96 Million
Q2 2020 Jul 23, 2020	SELL	$76.57 - $98.0 $134,303 - $171,892	-1,754 Reduced 3.09%	54,929 $5.02 Million
Q1 2020 May 01, 2020	SELL	$62.82 - $91.86 $362,659 - $530,307	-5,773 Reduced 9.24%	56,683 $4.47 Million
Q4 2019 Jan 28, 2020	SELL	$78.51 - $87.4 $116,194 - $129,352	-1,480 Reduced 2.31%	62,456 $5.43 Million
Q3 2019 Oct 28, 2019	SELL	$81.84 - $88.74 $201,244 - $218,211	-2,459 Reduced 3.7%	63,936 $5.35 Million
Q2 2019 Aug 01, 2019	BUY	$72.88 - $85.0 $5,466 - $6,375	75 Added 0.11%	66,395 $5.58 Million
Q1 2019 May 08, 2019	SELL	$66.22 - $80.06 $264 - $320	-4 Reduced 0.01%	66,320 $5.3 Million
Q4 2018 Feb 04, 2019	SELL	$65.56 - $74.27 $24,191 - $27,405	-369 Reduced 0.55%	66,324 $4.8 Million
Q3 2018 Nov 01, 2018	SELL	$60.81 - $73.36 $29,979 - $36,166	-493 Reduced 0.73%	66,693 $4.89 Million
Q2 2018 Aug 10, 2018	BUY	$57.57 - $63.54 $1.11 Million - $1.23 Million	19,336 Added 40.41%	67,186 $4.1 Million
Q1 2018 Apr 10, 2018	SELL	$56.27 - $63.62 $5,795 - $6,552	-103 Reduced 0.21%	47,850 $2.87 Million
Q4 2017 Jan 16, 2018	SELL	$53.68 - $57.47 $45,359 - $48,562	-845 Reduced 1.73%	47,953 $2.74 Million
Q3 2017 Oct 16, 2017	BUY	$48.06 - $53.64 $2.35 Million - $2.62 Million	48,798	48,798 $2.6 Million

Others Institutions Holding ABT

# of Institutions

3,538

Shares Held

1.38B

Call Options Held

9.75M

Put Options Held

8.87M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $233B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hartford Financial Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hartford Financial Management Inc. with notifications on news.

Account

Hartford Financial Management Inc. Abbott Laboratories Transaction History